What Is The Predicted Revenue Outlook For The Global Infectious Disease Molecular Diagnostics Market To Surpass $36.98 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Infectious Disease Molecular Diagnostics Market?
The market size for infectious disease molecular diagnostics has seen robust growth recently. An increase from $28.95 billion in 2024 to $30.46 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 5.2%. Factors contributing to the growth during the historic period include an escalating presence of infectious diseases, the growing need for prompt and accurate diagnostics, multiple occurrences of global outbreaks and pandemics, improved healthcare awareness and accessibility, alongside a surge in investments for diagnostic research and technology.
There is an anticipation of robust expansion in the infectious disease molecular diagnostics market size in the coming years. The market is projected to escalate to $36.98 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%. This growth during the prediction period can be credited to factors such as the rising use of point-of-care testing, a heightened focus on personalized medicine, increased governmental efforts to control infectious diseases, the expansion of healthcare infrastructure in developing markets, and the escalating incidence of respiratory diseases. Key trends for the forecast period encompass improvements in real-time polymerase chain reaction technology, the sophisticated integration of artificial intelligence within diagnostic platforms, the creation of multiplex testing panels, innovation in portable and domestic diagnostic kits, and advancements in automating molecular diagnostic workflows.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
Which Industry Forces Are Driving The Infectious Disease Molecular Diagnostics Market Forward?
The surge in infectious diseases is anticipated to stimulate the expansion of the infectious disease molecular diagnostics market. These diseases, instigated by harmful microorganisms like bacteria, fungi, viruses, or parasites, can be directly or indirectly transmitted from an individual to another. The growing incidence of infectious diseases can be chiefly attributed to globalization and expanded travel, which foster swift cross-border spread of pathogens, converting localized disease outbreaks into worldwide health crises. Infectious disease molecular diagnostics contribute to the management of these diseases by ensuring swift and precise pathogen identification at the genetic level. This aids early detection, precise treatment, and successful outbreak containment. For instance, the US Centers for Disease Control and Prevention reported that the United States documented 8,331 tuberculosis (TB) instances in 2022, marking a 5.9% surge from 2021. Consequently, the escalating prevalence of infectious diseases is fuelling the expansion of the infectious disease molecular diagnostics market.
How Is The Infectious Disease Molecular Diagnostics Market Organized By Different Segments?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Mass Spectrometry, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
What Current And Upcoming Trends Are Shaping The Infectious Disease Molecular Diagnostics Market?
Leading firms in the infectious disease molecular diagnostics market are concentrating their efforts on creating ground-breaking solutions like real-time polymerase chain reaction kits. These kits can prompt extensive and precise detection of infectious pathogens. These real-time polymerase chain reaction (PCR) kits act as diagnostic instruments that enhance and concurrently identify specific genetic material of pathogens instantly, enabling quick and precise detection of infectious diseases. For example, in February 2023, Thermo Fisher Scientific Inc., an American biotechnology and life sciences company, introduced Applied Biosystems TaqPath polymerase chain reaction kits in India, specifically for infectious diseases identification. These kits are expedited, ultra-sensitive multiplex diagnostic solutions that permit real-time PCR detection of infectious disease targets using a comprehensive workflow from ribonucleic acid extraction to diagnostic report production, generally in less than 4 hours. These kits include multiplexed assays that target numerous genomic regions of pathogens, integrate internal process controls, and deliver automated data analysis, thus minimizing user error and improving result reliability.
Who Are The Primary Market Leaders In The Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel‑Ortho Corporation, Sysmex Corporation, Bio‑Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Access The Complete Report Here:
How Do Regional Dynamics Influence The Infectious Disease Molecular Diagnostics Market Performance?
North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2025, By The Business Research Company
Infection Prevention Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Surveillance Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/surveillance-technology-global-market-report
Surgical Site Infection Control Global Market Report 2025
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
